GETY vs GUTS
GETY: Getty Images is a leading digital visual content marketplace currently undergoing a strategic review of its capital structure amidst significant liquidity and litigation challenges. GUTS: Fractyl Health is developing innovative procedural and gene therapy treatments aiming to address the root causes of obesity and type 2 diabetes.
Side-by-side fundamentals
| Metric | GETY | GUTS | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $0.02 | $1.33 | |
| Market cap | $8M | $18M | |
| Net margin FY2025, SEC XBRL | -21.0% | n/a | |
| Operating margin FY2025, SEC XBRL | +8.6% | n/a | |
| ROE FY2025, SEC XBRL | -34.3% | n/a | |
| ROA FY2025, SEC XBRL | -6.4% | -116.1% | GETY higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | 6.07 | n/a | |
| Revenue growth (YoY) FY2025, SEC XBRL | +4.5% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +1.9% | n/a | |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-03 | 1.63 | 1.00 | |
| 1-year return as of 2026-10-20 close | -99.0% | -92.0% | GUTS higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.